Novartis Oncology announces that the U.S. Food and Drug Administration has approved Femara(R) (letrozole tablets) for the first-line treatment of postmenopausal women with hormone receptor positive or ...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that APP Pharmaceuticals will immediately begin marketing Letrozole Tablets in the U.S., after the U.S.

Salpingo Oophorectomy Reduces Ovarian and Breast Cancer Risk In the largest prospective follow-up study to date, researchers confirm a protective effect. But they also found important differences in ...

PITTSBURGH Mylan on Monday announced that it has entered into a settlement agreement with Novartis Pharmaceuticals that will allow the generic manufacture to introduce a generic version of Novartis' ...

Postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer: The ENGOT-EN2/DGCG trial. Background: Endometrial cancer (EC ...

Results of a Belgian multicenter retrospective study to determine the incidence of HER2 gene amplification in patients scored as immunohistochemistry 0 or 1+. Background: The crosstalk between the ER ...